-
Two recent reports strongly suggest that Elans AN-1792 Alzheimers vaccine, which was withdrawn from clinical trials after several Alzheimers disease (AD) patients developed severe brain inflammation, did in fact succeed in altering the course of AD in some cases.
-
Intracranial balloon angioplasty and stent placement now are available to patients suffering from intracranial stenosis that involves the vertebrobasilar arteries (VBA). At present, however, no consensus exists regarding the role of endovascular procedures vs best medical management.
-
In this original study, 500 consecutive pediatric referrals for neurologic consultation were assessed to determine what influence, if any, was played by the history, neurologic examination, and investigations, with respect to final diagnosis and patient management.
-
Filippi and colleagues performed conventional brain MRIs and whole-brain N-acetylaspartate (WBNAA) measurements with proton magnetic resonance spectroscopy in 31 patients presenting with clinically isolated syndromes suggestive of multiple sclerosis (MS).
-
The Women's Health Initiatives (WHI) was halted 1 year ago, but fallout from this landmark study continues. The study was designed to identify the risks or benefits of estrogen plus progesterone vs placebo in healthy postmenopausal women.
-
Influenza Vaccination and Reduction in Hospitalizations; Screening Men for Prostate and Colorectal Cancer; Weight Loss in CHF and Treatment with ACE-I; Impaired Fasting Glucose vs Impaired Glucose Tolerance; Risk Stratification in Long-QT Syndrome; EBCT, Motivation, Behavioral Change, and Cardiovascular Risk Profile
-
The pattern of restenosis in sirolimus-eluting stents is focal and mainly inside the stent.
-
Data do not support early implantation of prophylactic ICDs in patients with nonischemic cardiomyopathy.
-
A new classification of blood pressure in adults is suggested, with normal blood pressure (BP) as < 120 mm Hg and < 80 mm Hg.
-
The Women's Health Initiatives (WHI) was halted 1 year ago, but fallout from this landmark study continues. The study was designed to identify the risks or benefits of estrogen plus progesterone vs placebo in healthy postmenopausal women.
